The role of adipocytes in the modulation of iron metabolism in obesity

Obesity Reviews

Volumn 14, Issue 10, 2013, Pages 771-779

  Coimbra, S ^a,b   Catarino, C ^a,c   Santos Silva, A ^a,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b INSTITUTO DE INVESTIGAÇÃO E FORMAÇÃO AVANÇADA EM CIÊNCIAS E TECNOLOGIAS DA SAÚDE   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Adipocyte hemojuvelin; Adipocyte hepcidin; Hepcidin; Obesity

Indexed keywords

BONE MORPHOGENETIC PROTEIN 6; C REACTIVE PROTEIN; FERROPORTIN; FERROUS ION; HEMOJUVELIN; HEPCIDIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; IRON; JANUS KINASE 2; LEPTIN; MATRIPTASE; MATRIPTASE 2; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; ENDOCYTOSIS; ERYTHROPOIESIS; INFLAMMATION; INTERNALIZATION; IRON KINETICS; IRON METABOLISM; IRON TRANSPORT; METABOLIC REGULATION; OBESITY; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT;

ADIPOCYTE HEMOJUVELIN; ADIPOCYTE HEPCIDIN; HEPCIDIN; OBESITY;

ADIPOCYTES; ADIPOSE TISSUE; ERYTHROPOIESIS; GPI-LINKED PROTEINS; HEPCIDINS; HUMANS; INTERLEUKIN-6; IRON; LEPTIN; OBESITY;

EID: 84883812763     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12057     Document Type: Review

References (78)

1. Tulchinsky TH. Micronutrient deficiency conditions: global health issues. Public Health Rev 2010; 32: 243-255.
2. Nead KG, Halterman JS, Kaczorowski JM, Auinger P, Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004; 114: 104-108.
3. Yanoff LB, Menzie CM, Denkinger B etal. Inflammation and iron deficiency in the hypoferremia of obesity. Int J Obes (Lond) 2007; 31: 1412-1419.
4. Lecube A, Carrera A, Losada E, Hernandez C, Simo R, Mesa J. Iron deficiency in obese postmenopausal women. Obesity (Silver Spring) 2006; 14: 1724-1730.
5. Zimmermann MB, Zeder C, Muthayya S etal. Adiposity in women and children from transition countries predicts decreased iron absorption, iron deficiency and a reduced response to iron fortification. Int J Obes (Lond) 2008; 32: 1098-1104.
6. Pinhas-Hamiel O, Newfield RS, Koren I, Agmon A, Lilos P, Phillip M. Greater prevalence of iron deficiency in overweight and obese children and adolescents. Int J Obes Relat Metab Disord 2003; 27: 416-418.
7. Tussing-Humphreys LM, Liang H, Nemeth E, Freels S, Braunschweig CA. Excess adiposity, inflammation, and iron-deficiency in female adolescents. J Am Diet Assoc 2009; 109: 297-302.
8. Ausk KJ, Ioannou GN. Is obesity associated with anaemia of chronic disease? A population-based study. Obesity (Silver Spring) 2008; 16: 2356-2361.
9. Sanad M, Osman M, Gharib A. Obesity modulate serum hepcidin and treatment outcome of iron deficiency anaemia in children: a case control study. Ital J Pediatr 2011; 37: 34.
10. Menzie CM, Yanoff LB, Denkinger BI etal. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc 2008; 108: 145-148.
11. Anty R, Dahman M, Iannelli A etal. Bariatric surgery can correct iron depletion in morbidly obese women: a link with chronic inflammation. Obes Surg 2008; 18: 709-714.
12. Baumgartner J, Smuts CM, Aeberli I, Malan L, Tjalsma H, Zimmermann MB. Overweight impairs efficacy of iron supplementation in iron-deficient South African children: a randomized controlled intervention. Int J Obes (Lond) 2013; 37: 24-30.
13. Nemeth E, Tuttle MS, Powelson J etal. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004; 306: 2090-2093.
14. De Domenico I, Ward DM, Langelier C etal. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. Mol Biol Cell 2007; 18: 2569-2578.
15. De Domenico I, Zhang TY, Koening CL etal. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 2010; 120: 2395-2405.
16. Koorts AM, Viljoen M. Ferritin and ferritin isoforms I: structure-function relationships, synthesis, degradation and secretion. Arch Physiol Biochem 2007; 113: 30-54.
17. Mena NP, Esparza A, Tapia V, Valdes P, Nunez MT. Hepcidin inhibits apical iron uptake in intestinal cells. Am J Physiol Gastrointest Liver Physiol 2008; 294: G192-G198.
18. Brasse-Lagnel C, Karim Z, Letteron P, Bekri S, Bado A, Beaumont C. Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation. Gastroenterology 2011; 140: 1261-1271 e1.
19. Nicolas G, Chauvet C, Viatte L etal. The gene encoding the iron regulatory peptide hepcidin is regulated by anaemia, hypoxia, and inflammation. J Clin Invest 2002; 110: 1037-1044.
20. Huang H, Constante M, Layoun A, Santos MM. Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 2009; 113: 3593-3599.
21. Ashby DR, Gale DP, Busbridge M etal. Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica 2010; 95: 505-508.
22. Rankin EB, Biju MP, Liu Q etal. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J Clin Invest 2007; 117: 1068-1077.
23. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood 2008; 112: 4292-4297.
24. Weinstein DA, Roy CN, Fleming MD, Loda MF, Wolfsdorf JI, Andrews NC. Inappropriate expression of hepcidin is associated with iron refractory anaemia: implications for the anaemia of chronic disease. Blood 2002; 100: 3776-3781.
25. Melis MA, Cau M, Congiu R etal. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anaemia refractory to oral iron. Haematologica 2008; 93: 1473-1479.
26. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 2007; 117: 1933-1939.
27. Wrighting DM, Andrews NC. Interleukin-6 induces hepcidin expression through STAT3. Blood 2006; 108: 3204-3209.
28. Verga Falzacappa MV, Vujic Spasic M, Kessler R, Stolte J, Hentze MW, Muckenthaler MU. STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood 2007; 109: 353-358.
29. Nemeth E, Rivera S, Gabayan V etal. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004; 113: 1271-1276.
30. Darshan D, Frazer DM, Wilkins SJ, Anderson GJ. Severe iron deficiency blunts the response of the iron regulatory gene Hamp and pro-inflammatory cytokines to lipopolysaccharide. Haematologica 2010; 95: 1660-1667.
31. Zhang AS, Enns CA. Molecular mechanisms of normal iron homeostasis. Hematology Am Soc Hematol Educ Program 2009; 2009: 207-214.
32. Du X, She E, Gelbart T etal. The serine protease TMPRSS6 is required to sense iron deficiency. Science 2008; 320: 1088-1092.
33. Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 2005; 115: 2180-2186.
34. Andriopoulos B Jr, Corradini E, Xia Y etal. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 2009; 41: 482-487.
35. Folgueras AR, de Lara FM, Pendas AM etal. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 2008; 112: 2539-2545.
36. Lee DH, Zhou LJ, Zhou Z etal. Neogenin inhibits HJV secretion and regulates BMP-induced hepcidin expression and iron homeostasis. Blood 2010; 115: 3136-3145.
37. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab 2008; 8: 502-511.
38. Zhang AS, West AP Jr, Wyman AE, Bjorkman PJ, Enns CA. Interaction of hemojuvelin with neogenin results in iron accumulation in human embryonic kidney 293 cells. J Biol Chem 2005; 280: 33885-33894.
39. Papanikolaou G, Samuels ME, Ludwig EH etal. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004; 36: 77-82.
40. Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HY. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 2008; 111: 5195-5204.
41. Lin L, Nemeth E, Goodnough JB, Thapa DR, Gabayan V, Ganz T. Soluble hemojuvelin is released by proprotein convertase-mediated cleavage at a conserved polybasic RNRR site. Blood Cells Mol Dis 2008; 40: 122-131.
42. Silvestri L, Pagani A, Camaschella C. Furin-mediated release of soluble hemojuvelin: a new link between hypoxia and iron homeostasis. Blood 2008; 111: 924-931.
43. Zhang AS, Anderson SA, Meyers KR, Hernandez C, Eisenstein RS, Enns CA. Evidence that inhibition of hemojuvelin shedding in response to iron is mediated through neogenin. J Biol Chem 2007; 282: 12547-12556.
44. Lin L, Goldberg YP, Ganz T. Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin. Blood 2005; 106: 2884-2889.
45. Krijt J, Vokurka M, Chang KT, Necas E. Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood 2004; 104: 4308-4310.
46. Krijt J, Fujikura Y, Sefc L, Vokurka M, Hlobenova T, Necas E. Hepcidin downregulation by repeated bleeding is not mediated by soluble hemojuvelin. Physiol Res 2010; 59: 53-59.
47. Maxson JE, Chen J, Enns CA, Zhang AS. Matriptase-2- and proprotein convertase-cleaved forms of hemojuvelin have different roles in the down-regulation of hepcidin expression. J Biol Chem 2010; 285: 39021-39028.
48. Henry SL, Bensley JG, Wood-Bradley RJ, Cullen-McEwen LA, Bertram JF, Armitage JA. White adipocytes: more than just fat depots. Int J Biochem Cell Biol 2012; 44: 435-440.
49. Mamus SW, Beck-Schroeder S, Zanjani ED. Suppression of normal human erythropoiesis by gamma interferon in vitro. Role of monocytes and T lymphocytes. J Clin Invest 1985; 75: 1496-1503.
50. Means RT Jr, Krantz SB. Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest 1993; 91: 416-419.
51. Grigorakaki C, Morceau F, Chateauvieux S, Dicato M, Diederich M. Tumor necrosis factor alpha-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expression. Biochem Pharmacol 2011; 82: 156-166.
52. Rogers JT. Ferritin translation by interleukin-1and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes. Blood 1996; 87: 2525- 2537.
53. Matsunaga T, Shoji A, Gu N etal. gamma-Tocotrienol attenuates TNF-alpha-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes. Mol Med Rep 2012; 5: 905-909.
54. Pini M, Rhodes DH, Fantuzzi G. Hematological and acute-phase responses to diet-induced obesity in IL-6 KO mice. Cytokine 2011; 56: 708-716.
55. Huang YH, Chuang JH, Yang YL, Huang CC, Wu CL, Chen CL. Cholestasis downregulate hepcidin expression through inhibiting IL-6-induced phosphorylation of signal transducer and activator of transcription 3 signaling. Lab Invest 2009; 89: 1128-1139.
56. Harkins JM, Moustaid-Moussa N, Chung YJ etal. Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J Nutr 2004; 134: 2673-2677.
57. Ye J, Gao Z, Yin J, He Q. Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am J Physiol Endocrinol Metab 2007; 293: E1118-E1128.
58. Wang B, Wood IS, Trayhurn P. Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 2007; 455: 479-492.
59. Hintze KJ, Snow D, Nabor D, Timbimboo H. Adipocyte hypoxia increases hepatocyte hepcidin expression. Biol Trace Elem Res 2011; 143: 764-771.
60. Pietilainen KH, Kannisto K, Korsheninnikova E etal. Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins. J Clin Endocrinol Metab 2006; 91: 2776-2781.
61. Chow VT, Phoon MC. Measurement of serum leptin concentrations in university undergraduates by competitive ELISA reveals correlations with body mass index and sex. Adv Physiol Educ 2003; 27: 70-77.
62. Maffei M, Halaas J, Ravussin E etal. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat Med 1995; 1: 1155-1161.
63. Enriori PJ, Evans AE, Sinnayah P, Cowley MA. Leptin resistance and obesity. Obesity (Silver Spring) 2006; 14(Suppl. 5): 254S-258S.
64. Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 1999; 194: 6-11.
65. Lolmede K, Durand de Saint Front V, Galitzky J, Lafontan M, Bouloumie A. Effects of hypoxia on the expression of proangiogenic factors in differentiated 3T3-F442A adipocytes. Int J Obes Relat Metab Disord 2003; 27: 1187-1195.
66. Wang B, Wood IS, Trayhurn P. Hypoxia induces leptin gene expression and secretion in human preadipocytes: differential effects of hypoxia on adipokine expression by preadipocytes. J Endocrinol 2008; 198: 127-134.
67. Failla ML, Kennedy ML, Chen ML. Iron metabolism in genetically obese (ob/ob) mice. J Nutr 1988; 118: 46-51.
68. Chung B, Matak P, McKie AT, Sharp P. Leptin increases the expression of the iron regulatory hormone hepcidin in HuH7 human hepatoma cells. J Nutr 2007; 137: 2366-2370.
69. Chung J, Kim MS, Han SN. Diet-induced obesity leads to decreased hepatic iron storage in mice. Nutr Res 2011; 31: 915-921.
70. del Giudice EM, Santoro N, Amato A etal. Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab 2009; 94: 5102-5107.
71. Amato A, Santoro N, Calabro P etal. Effect of body mass index reduction on serum hepcidin levels and iron status in obese children. Int J Obes (Lond) 2010; 34: 1772-1774.
72. Bekri S, Gual P, Anty R etal. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology 2006; 131: 788-796.
73. Vokurka M, Lacinova Z, Kremen J etal. Hepcidin expression in adipose tissue increases during cardiac surgery. Physiol Res 2010; 59: 393-400.
74. Andrews M, Arredondo M. Hepatic and adipocyte cells respond differentially to iron overload, hypoxic and inflammatory challenge. Biometals 2012; 25: 749-759.
75. Tussing-Humphreys L, Frayn KN, Smith SR etal. Subcutaneous adipose tissue from obese and lean adults does not release hepcidin in vivo. ScientificWorldJournal 2011; 11: 2197-2206.
76. Luciani N, Brasse-Lagnel C, Poli M etal. Hemojuvelin: a new link between obesity and iron homeostasis. Obesity (Silver Spring) 2011; 19: 1545-1551.
77. Aeberli I, Hurrell RF, Zimmermann MB. Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children. Int J Obes (Lond) 2009; 33: 1111-1117.
78. Tussing-Humphreys LM, Nemeth E, Fantuzzi G etal. Elevated systemic hepcidin and iron depletion in obese premenopausal females. Obesity (Silver Spring) 2010; 18: 1449-1456.